We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Sekisui Diagnostics

  Gold Sekisui Diagnostics manufactures and distributes clinical chemistry products, such as routine and specialty tests, an... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Multiple Coagulation Parameters Predict Postoperative Bleeding Volume in Cardiovascular Surgery

By LabMedica International staff writers
Posted on 02 Dec 2021
Print article
Image: The CP3000Automated Coagulation System measures various coagulation factors (Photo courtesy of Sekisui Medical Company)
Image: The CP3000Automated Coagulation System measures various coagulation factors (Photo courtesy of Sekisui Medical Company)
Coagulopathy and massive bleeding are severe complications of cardiovascular surgery, particularly occurring after procedures requiring prolonged cardiopulmonary bypass (CPB). During surgery massive transfusion of blood products may become necessary.

Reliable and predictive laboratory tests on coagulation function will help guide clinicians to appropriate transfusion and possibly decrease variability in transfusion practices. Appropriate coagulation parameters would help to predict bleeding after cardiovascular surgery and measuring multiple coagulation parameters may prove useful.

Medical Laboratorians at the Asahikawa Medical University Hospital (Asahikawa, Japan) and their colleagues in a prospectively study collected cohort of 48 patients undergoing cardiovascular surgery from November 2015 to March 2016. They examined the association between coagulation parameters and bleeding volume. The median age of the cohort was 69 years, 29 males and 19 females and all were ethnically Asian.

The team measured prothrombin time (PT) or activated partial thromboplastin time (APTT) and fibrinogen (Fib) with the Coapresta2000 automated analyzer (coagulation one-stage assay (Sekisui Medical Company, Tokyo, Japan). Activities of coagulation factor II (FII), FV, FVII, FVIII, FIX, FX, FXI and FXII were measured with Sekisui Medical Company’s Coapresta3000. α2 Plasmin inhibitor (α2PI, synthetic substrate assay), antithrombin (AT, synthetic substrate assay), thrombin-antithrombin complex (TAT, chemiluminescent enzyme immunoassay) and FXIII activity (synthetic substrate assay) were measured using the STACIA automated analyzer (LSI Medience Corporation, Tokyo, Japan).

The scientists reported that bleeding volume during surgery was 2,269 (174–10,607) mL. Number of transfusion units during surgery were packed red blood cells 12 (0–30) units, fresh frozen plasma 12 (0–44) units, platelets 20 (0–60) units and intraoperative autologous blood collection 669 (0–4,439) mL. Post-surgery activities of coagulation factors II (FII), FV, FVII, FVIII, FIX, FX, FXI and FXII were decreased. Values of fibrinogen, antithrombin, α2 plasmin inhibitor (α2PI) and FXIII were also decreased. Values of thrombin-antithrombin complex (TAT) were increased. Values of FII, FIX, FXI and α2PI before surgery were negatively correlated with bleeding volume. Level of FIX after surgery was negatively correlated with bleeding volume and level of TAT after surgery was positively correlated with bleeding volume.

The authors concluded that FII, FIX, FXI, FXIII and α2PI are associated with postoperative bleeding volume. Diluted coagulopathy, decrease in stabilized fibrin due to decrease in FXIII and hyperfibrinolysis due to decrease in α2PI may contribute to hemostatic defect. Thrombin burst due to operative stress as represented by increase in TAT values may also contribute to hemostatic defect. The study was published on October 9, 2021 in the Thrombosis Journal.

Related Links:
Asahikawa Medical University Hospital
Sekisui Medical Company
LSI Medience Corporation


New
Gold Supplier
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
New
Zika Virus ELISA Test
RecombiLISA Zika IgM ELISA CE
New
Infliximab Rapid Test
Quantum Blue Infliximab
New
Multichannel Adjustable-Volume Pipettor
Cole-Parmer Essentials

Print article

Channels

Molecular Diagnostics

view channel
Image: New chip could make treating metastatic cancer easier and faster (Photo courtesy of Georgia Institute of Technology)

Simple Blood Test Detection Method Could Revolutionize Cancer Treatment

Cancer spreads via circulating tumor cells (CTCs) that travel through the blood to other organs, and they are nearly impossible to track. When a tumor starts metastasizing, it sheds its cell into the blood.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.